| Nov 7 |
HilleVax GAAP EPS of -$0.52 misses by $0.10
|
| Nov 7 |
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
|
| Oct 14 |
What Makes HilleVax (HLVX) a New Buy Stock
|
| Aug 9 |
HilleVax GAAP EPS of -$0.83
|
| Aug 8 |
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
| Aug 1 |
HilleVax slashes workforce by 40% after norovirus vaccine trial failure
|
| Jul 31 |
Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
|
| Jul 31 |
HilleVax to cut 40% of its workforce
|
| Jul 31 |
HilleVax Announces Reduction in Force
|
| Jul 29 |
After Plunging -86.93% in 4 Weeks, Here's Why the Trend Might Reverse for HilleVax (HLVX)
|
